Hepatic Artery Embolization for Control of Symptoms, Octreotide Requirements, and Tumor Progression in Metastatic Carcinoid Tumors

This publication has 56 references indexed in Scilit:

• Carcinoid disease
  Diseases of the Colon & Rectum, 1997
• Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.
  Gut, 1996
• Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
  American Journal of Roentgenology, 1995
• Management of Gastroenteropancreatic Endocrine Tumors: The Place of Somatostatin Analogues
  Digestion, 1994
• Embolisation Therapy in the Midgut Carcinoid Syndrome: Just Tumour Ischaemia?
  Acta Oncologica, 1993
• Hepatic arterial embolization for metastatic hormone-secreting tumors technique, effectiveness, and complications
  Cancer, 1990
• Cytotoxic Treatment in Patients with Malignant Carcinoid Tumors: Response to streptozocin—alone or in combination with 5-FU
  Acta Oncologica, 1987
• Characterization of Effector Cells Mediating the Augmentation of Spontaneous Cell-Mediated Cytotoxicity Induced by Therapeutic Infarction of Human Renal Carcinomas
  Urologia Internationalis, 1984
• Role of hepatic arterial embolisation in the carcinoid syndrome.
  BMJ, 1983
• TREATMENT OF CARCINOID LIVER METASTASES BY HEPATIC-ARTERY EMBOLISATION
  The Lancet, 1977